関連する実験動画
Updated: Sep 9, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.0K
大量の輸血を必要とするトラウマ患者における高血小板と赤血球の比率と結果
Chi Peng1, Yibin Guo2, Fan Yang3
1Department of Emergency, Changhai hospital, Naval Medical University, Shanghai, 200433, China.
World journal of emergency surgery : WJES
|August 30, 2025
まとめ
血小板と赤血球 (PLT/ RBC) の比率が高い (0. 7以上) は,大量輸血によるトラウマ患者の死亡率を著しく低下させる. しかし,この増加した比率は,有害事象のリスクを高め,利益は1.5を超えて平準化します.
科学分野:
- トラウマ と 緊急 医療
- 輸血 医学
- 緊急 治療
背景:
- 制御不能の出血は トラウマ患者の主要な死因です
- 血小板と赤血球 (PLT/ RBC) の比率が高くなった場合,結果が改善される可能性があるが,最適な値は不明である.
- この研究では,大量の輸血によるトラウマ患者の死亡率に対するPLT/RBC比の影響を調査しています.
研究 の 目的:
- トラウマにおける大量輸血のための最適のPLT/RBC比率を決定する.
- PLT/RBC比と入院死亡率との関連を評価する.
- 輸血に関連する有害事象に対するPLT/RBC比の影響を評価する.
主な方法:
- 2014年から2018年までの国家トラウマデータバンク (NTDB) の遡及分析
- レベルI/IIのトラウマセンターでのED入院後24時間以内に大量輸血を受けた成人の患者を含む.
- 高PLT群 (PLT/RBC比> 0.7) と低PLT群 (比 ≤ 0.7) の結果の比較
主要な成果:
- 合計9,330人の患者が分析され,46. 1%が高いPLT/ RBC比であった.
- 死亡率は,PLT/ RBC比> 0. 7で著しく低下し,1.5以上で安定した.
- 高PLT群では24時間 (OR0. 45) と30日間の死亡率 (OR0. 66) が低下したが,PE,AKI,およびセプシスなどの有害事象が増加した.
結論:
- PLT/ RBC比> 0. 7は,大規模な輸血外傷患者の生存率の改善と関連しています.
- 高い比率は有害事象のリスクを増加させ,1.5以上の上限効果が観察された.
- これらの発見を検証し,輸血戦略を最適化するためにさらなる臨床試験が必要である.
関連する概念動画
Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K
Structure and Function of Platelets
1.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K
Blood Transfusion and Agglutination
11.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.2K
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K

